Drorit G. Merkel

Ramat Gan, TA, Israel

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Cladribine-based salvage therapy in relapsed/refractory AML: A multicenter retrospective study.

Cladribine-based salvage therapy in relapsed/refractory AML: A multicenter retrospective study.

Journal: Leukemia research
Published: June 07, 2026

Kundalini Yoga for Improving Patient-Reported Outcomes in Patients Diagnosed with Myelodysplastic Syndromes: A Pilot Study.

Kundalini Yoga for Improving Patient-Reported Outcomes in Patients Diagnosed with Myelodysplastic Syndromes: A Pilot Study.

Journal: Acta haematologica
Published: February 07, 2025

Analyzing Blood Cells of High-Risk Myelodysplastic Syndrome Patients Using Interferometric Phase Microscopy and Fluorescent Flow Cytometry.

Analyzing Blood Cells of High-Risk Myelodysplastic Syndrome Patients Using Interferometric Phase Microscopy and Fluorescent Flow Cytometry.

Journal: Bioengineering (Basel, Switzerland)
Published: January 21, 2024

MDS-Related Anemia Is Associated with Impaired Quality of Life but Improvement Is Not Always Achieved by Increased Hemoglobin Level.

MDS-Related Anemia Is Associated with Impaired Quality of Life but Improvement Is Not Always Achieved by Increased Hemoglobin Level.

Journal: Journal of clinical medicine
Published: August 04, 2023

The Effect of Oral Iron Chelator Deferiprone on Iron Overload and Oxidative Stress in Patients with Myelodysplastic Syndromes: A Study by the Israeli MDS Working Group.

The Effect of Oral Iron Chelator Deferiprone on Iron Overload and Oxidative Stress in Patients with Myelodysplastic Syndromes: A Study by the Israeli MDS Working Group.

Journal: Acta haematologica
Published: June 20, 2023

Acute Myeloid Leukemia Patients Requiring Two Cycles of Intensive Induction for Attainment of Remission Experience Inferior Survival Compared with Patients Requiring a Single Course of Induction Chemotherapy.

Acute Myeloid Leukemia Patients Requiring Two Cycles of Intensive Induction for Attainment of Remission Experience Inferior Survival Compared with Patients Requiring a Single Course of Induction Chemotherapy.

Journal: Clinical lymphoma, myeloma & leukemia
Published: June 30, 2021

Reassessing the role of high dose cytarabine and mitoxantrone in relapsed/refractory acute myeloid leukemia.

Reassessing the role of high dose cytarabine and mitoxantrone in relapsed/refractory acute myeloid leukemia.

Journal: Oncotarget
Published: January 30, 2020

Is fluorescence in-situ hybridization sufficient in patients with myelodysplastic syndromes and insufficient cytogenetic testing?

Is fluorescence in-situ hybridization sufficient in patients with myelodysplastic syndromes and insufficient cytogenetic testing?

Journal: Leukemia & lymphoma
Published: September 07, 2018

Coping with Iron Deficiency and Iron Deficiency Anemia in Combat Recruits.

Coping with Iron Deficiency and Iron Deficiency Anemia in Combat Recruits.

Journal: Acta haematologica
Published: January 18, 2018

Gender disparities in the functional significance of anemia among apparently healthy adults.

Gender disparities in the functional significance of anemia among apparently healthy adults.

Journal: European journal of haematology
Published: January 19, 2017

Second line azacitidine for elderly or infirmed patients with acute myeloid leukemia (AML) not eligible for allogeneic hematopoietic cell transplantation-a retrospective national multicenter study.

Second line azacitidine for elderly or infirmed patients with acute myeloid leukemia (AML) not eligible for allogeneic hematopoietic cell transplantation-a retrospective national multicenter study.

Journal: Annals of hematology
Published: September 17, 2016

Clinical Experience With Deferiprone Treatment for Friedreich Ataxia.

Clinical Experience With Deferiprone Treatment for Friedreich Ataxia.

Journal: Journal of child neurology
Published: July 23, 2015
Showing 1-12 of 18

Last Updated: 09/26/2026